GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...

Small, persistent changes in the nose or face are easy to ignore, but in some cases they are the earliest signs of a much ...

The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Profs Carl Philpott and Claire Hopkins discuss how the MACRO trial challenges long-held assumptions about chronic ...

Angela Read thought she had a sinus infection, soon she discovered her condition was much more serious. She's grateful to the ...

Cystic fibrosis, a genetic disorder, affects lungs and other organs. It causes thick mucus buildup. Researchers have ...

GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines ...

Denmark: A new systematic review and meta-analysis has shed light on how effectively biologic therapies can help restore the ...

Credit: Getty Images Researchers evaluated adults with severe CRSwNP who had used tezepelumab to determine whether treatment effects continued after treatment ceased. Among patients with CRSwNP who ...

A research team from the Research Center Borstel, Leibniz Lung Center (FZB), Kiel University (CAU), the University of Lübeck (UzL), and the University Medical Center Schleswig-Holstein (UKSH), ...

A blocked nostril could be due to allergies, nasal polyps, a deviated septum, or other causes. Use saline rinses and stay hydrated to help clear a blocked nostril. If symptoms persist, see a ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...